ICM
CBT icon

Invenomic Capital Management’s Cabot Corp CBT Stock Holding History

Invenomic Capital Management’s Portfolio CBT Stock Details CBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,168
Closed -$1.41M – 146
2022
Q4 		$1.41M Sell
21,168
-261,236
-93% -$18.2M 0.1% 127
2022
Q3 		$18M Sell
282,404
-8,015
-3% -$565K 1.55% 17
2022
Q2 		$18.5M Buy
290,419
+142,893
+97% +$9.77M 1.31% 17
2022
Q1 		$8.11M Buy
147,526
+40,502
+38% +$2.67M 0.87% 35
2021
Q4 		$6.01M Buy
107,024
+35,087
+49% +$1.93M 1.29% 21
2021
Q3 		$3.6M Buy
71,937
+49,780
+225% +$2.66M 1.17% 31
2021
Q2 		$1.26M Sell
22,157
-38,668
-64% -$2.27M 0.3% 68
2021
Q1 		$3.19M Buy
60,825
+11,171
+22% +$551K 0.71% 28
2020
Q4 		$2.23M Buy
49,654
+21,134
+74% +$877K 0.57% 35
2020
Q3 		$1.03M Sell
28,520
-11,968
-30% -$455K 0.57% 56
2020
Q2 		$1.5M Buy
40,488
+5,454
+16% +$182K 1.11% 31
2020
Q1 		$915K Sell
35,034
-29,255
-46% -$1.11M 0.75% 48
2019
Q4 		$3.06M Buy
+64,289
New +$2.98M 1.23% 33

Other funds holding CBT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invenomic Capital Management's CBT Position: Q1 2023 in Review

Invenomic Capital Management sold out of Cabot Corp (CBT) in Q1 2023, closing a stake of 21,168 shares — an estimated $1.41M sold.

Invenomic Capital Management first reported a position in CBT in Q4 2019 and held it in 13 quarters. The position peaked at $18.5M in Q2 2022. 304 funds tracked by Wall St. Rank hold CBT as of Q1 2023.

  • Invenomic Capital Management reported no remaining Cabot Corp position as of Q1 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 21,168 Cabot Corp shares in Q1 2023, an estimated $1.41M.
  • Invenomic Capital Management first reported a position in Cabot Corp in Q4 2019 and held it in 13 quarters.
  • Invenomic Capital Management's Cabot Corp position peaked at $18.5M in Q2 2022.
  • 304 funds tracked by Wall St. Rank held Cabot Corp as of Q1 2023.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.